Safety & biocompatibility framework
This page defines the general Safety & Biocompatibility Framework applicable to 3Dresyns® photopolymer resin systems. It provides a conceptual and technical reference that applies across materials, technologies and applications and must be read together with the relevant Instructions for Use (IFU) and any application-specific documentation.
This page does not replace any IFU and does not constitute a regulatory approval or certification.
Core principle
Safety and biocompatibility are central considerations in the development, communication and use of photopolymer materials for additive manufacturing. At 3Dresyns®, safety and biocompatibility are addressed through a system-based and process-aware framework that recognizes the multivariable nature of photopolymer 3D printing.
Biocompatibility is not an intrinsic property of a liquid resin alone. It is an outcome of the complete material–process–application system.
Definition of biocompatibility in additive manufacturing
In the context of photopolymer additive manufacturing, biocompatibility refers to the ability of a printed part, produced under defined conditions, to perform its intended function without causing unacceptable biological responses in a specific application.
Biocompatibility outcomes depend on material formulation, formulation version, printer technology, printing parameters, post-processing workflow and intended use conditions.
What biocompatibility means in photopolymer systems
In photopolymer additive manufacturing, biological response depends on the complete manufacturing process, including:
- Resin formulation and version
- Printer technology and exposure strategy
- Printing parameters and orientation
- Washing and post-curing conditions
- Final geometry, surface finish and intended use
As a result, biocompatibility must be understood as a process-dependent outcome, not as a fixed material constant.
Raw materials versus finished medical devices
3Dresyns photopolymer resins are supplied as raw materials, not as finished medical or dental devices.
A finished medical device is defined by:
- Its intended medical use
- Its final form and geometry
- Its validated manufacturing process
- Its regulatory approval and certification
The transformation of a resin into a medical or dental device is performed by the user and falls under the responsibility of the device manufacturer.
Process dependency and system-level responsibility
Printing, washing and post-curing conditions directly influence polymer conversion, surface chemistry and residual extractables. As a result, changes in workflow may significantly affect both safety and biocompatibility outcomes.
Safety and biocompatibility outcomes may be influenced by:
- Undercuring or overcuring
- Incomplete washing or post-processing
- Formulation modification or additive use
- Aging, contamination or improper storage
Small deviations in processing conditions may significantly affect surface chemistry, extractables, leachables and biological response. For this reason, safety and biocompatibility must be evaluated and maintained at the system level rather than assumed from material composition alone.
Role of printing and post-processing
Printing and post-processing steps play a critical role in determining final safety and biocompatibility. Parameters such as exposure energy, washing efficiency, post-curing intensity and duration directly influence:
- Residual monomer content
- Surface reactivity
- Mechanical stability
- Long-term behavior
For this reason, strict adherence to qualified workflows is essential.
Scope and limitations of biocompatible material systems
3Dresyns develops photopolymer systems intended to support applications where biocompatibility considerations are relevant, including medical, dental, research and laboratory contexts.
These materials are designed to operate within defined application scopes and qualified workflows. They are not presented as universally biocompatible under all conditions or for all uses.
Relationship between safety, testing and use
Safety and biocompatibility assessment relies on appropriate testing performed under reference configurations and recognized standards. Testing outcomes are valid only for the specific material version and workflow under which they were generated.
Instructions for Use (IFU) define the qualified processing conditions required to achieve expected performance and safety outcomes. Deviations from IFU may invalidate testing results and compromise biocompatibility.
Relationship with Instructions for Use (IFU)
3Dresyns Instructions for Use define qualified reference workflows under which typical performance and safety behavior are evaluated. IFUs are structured by levels:
- Core IFUs defining fundamental processing rules
- Technology-specific IFUs
- Application-specific IFUs
All IFUs must be applied coherently and hierarchically.
Validation and qualification
Biocompatibility and safety must be validated by the user for the intended application. Validation may include:
- Biological evaluation
- Chemical characterization
- Process reproducibility assessment
- Long-term performance testing
Results obtained under reference conditions may not apply if processing conditions are changed.
Safety, handling and responsible use
Photopolymer resins must be handled responsibly and in accordance with applicable safety guidelines. Users are responsible for:
- Following handling and storage recommendations
- Using appropriate personal protective equipment
- Preventing contamination and cross-mixing
- Disposing of materials in compliance with local regulations
Safety data and handling guidance must always be consulted before use.
Regulatory context and user responsibility
Regulatory frameworks for medical and dental devices apply to the finished device, not to the raw printing material alone. Manufacturers of final parts are responsible for:
- Process validation and qualification
- Risk assessment and biological evaluation
- Compliance with applicable standards and regulations
3Dresyns provides materials and technical documentation but does not assume regulatory responsibility for finished devices.
Responsibilities of material suppliers and users
3Dresyns is responsible for developing materials, defining qualified workflows, providing reference testing data and ensuring traceability through versioning and lot control.
Responsibility for final application validation, regulatory compliance and correct implementation rests with the device manufacturer, laboratory or user applying the material within a specific use case.
Transparency and responsible communication
3Dresyns is committed to transparent and responsible communication of safety and biocompatibility information. Performance data and guidance are presented as typical outcomes obtained under defined reference conditions, not as absolute or unconditional guarantees.
Statements regarding safety or biocompatibility:
- Refer to typical behavior under qualified conditions
- Do not constitute medical device approval
- Must not be generalized beyond their validated scope
Misleading or oversimplified claims should be avoided.
Governing principle
3Dresyns photopolymer resins are multivariable, process-dependent systems. Safety and biocompatibility are outcomes of qualified workflows, not intrinsic guarantees. Final validation and regulatory compliance remain the responsibility of the device manufacturer.
Need help?
If you need support selecting the appropriate IFU level, qualifying a workflow, or documenting a test configuration, contact our team at info@3dresyns.com.